 Mortality neoplasia Creutzfeldt-Jakob disease patients human pituitary growth hormone United Kingdom OBJECTIVE cause death incidence neoplasia patients human pituitary growth hormone DESIGN long term cohort study details death certification tumour registrations Office Population Censuses Surveys NHS central register PATIENTS patients male female short stature pituitary growth hormone Medical Research Council party health services human growth hormone committee MAIN OUTCOME MEASURES Death development neoplasia RESULTS patients male female years Fifty death neoplasia responsible growth hormone deficiency craniopharyngioma intracranial tumour leukaemia histiocytosis pituitary insufficiency patients Creutzfeldt-Jakob disease neurological disorders acute infection Other deaths unrelated growth hormone deficiency treatment Seventeen tumours patients growth hormone treatment patients previous intracranial neoplasia cranial irradiation Thirteen intracranial others Hodgkin lymphoma osteosarcoma carcinoma colon basal cell carcinoma CONCLUSIONS Recurrence progression intracranial tumours avoidable metabolic consequences hypopituitarism main causes death Growth hormone treatment new tumour development Creutzfeldt-Jakob disease pituitary growth hormone treatment United Kingdom cohort long term review